Havertown, PA, United States of America

Edward James Delikatny

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Edward James Delikatny: Innovator in Cancer Diagnosis and Treatment

Introduction

Edward James Delikatny is a prominent inventor based in Havertown, PA (US). He has made significant contributions to the field of cancer research, holding a total of 3 patents. His work focuses on innovative methods for diagnosing and treating cancer, particularly through the use of advanced compositions and molecular beacons.

Latest Patents

One of Delikatny's latest patents involves diagnosing and treating cancer. This invention relates to compositions and methods for diagnosing as well as treating cancer diseases associated with choline kinase (ChoK). Specifically, it includes a composition comprising an intrinsically fluorescent choline kinase inhibitor or a ChoK inhibitor operably linked to a fluorescent dye. This composition is capable of diagnosing and/or treating cancer diseases associated with ChoK.

Another significant patent is directed towards the in vivo detection of phospholipase activation. This invention features a phospholipid-based NIR molecular beacon, which includes a phospholipid moiety with an NIR fluorophore moiety covalently linked to a phospholipid glycerol backbone and a quencher moiety also covalently linked to the phospholipid glycerol backbone. Additionally, it provides methods for analyzing a sample for the presence of a phospholipase and identifying the activity of a phospholipase in vivo utilizing the phospholipid-based NIR molecular beacon.

Career Highlights

Delikatny is affiliated with the University of Pennsylvania, where he continues to advance his research and innovations in cancer treatment. His work has garnered attention for its potential impact on the medical field, particularly in improving diagnostic techniques and therapeutic options for cancer patients.

Collaborations

Throughout his career, Delikatny has collaborated with notable colleagues, including Gang Zheng and Anatoliy V Popov. These partnerships have contributed to the development of his innovative patents and research initiatives.

Conclusion

Edward James Delikatny is a key figure in the realm of cancer research, with a focus on innovative diagnostic and treatment methods. His contributions through his patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…